Design and In Vitro Characterization of Orally Disintegrating Modified Release Tablets of Naproxen Sodium
Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2020, Vol 17, Issue 5
Abstract
Objectives: The aim of this study was to prepare orally disintegrating, slow release tablets of naproxen sodium for prompt onset and sustained action required in many types of acute pain. Materials and Methods: Tablet formulations containing varying concentrations of croscarmellose sodium (a superdisintegrant) and Soluplus® (as release modifier) were prepared by wet granulation method using a single punch tablet machine. The prepared granules were evaluated for their bulk properties and the tablets were evaluated for hardness, disintegration time, and drug release profiles. Results: The results showed that the granules so prepared have good flow and compressional properties. A disintegration time of tablets <30 s was achieved by selecting an optimum concentration of croscarmellose sodium. The drug release from the tablets was sustained for 2 h by incorporating a suitable amount of Soluplus®. Conclusion: This study examined the use of Soluplus® (a novel solubilizer) for the first time as a release modifier of API from tablets.
Authors and Affiliations
Amjad HUSSAIN, Maham MISBAH, Nasir ABBAS, Muhammad IRFAN, Muhammad Sohail ARSHAD, Rahat SHAMIM, Nadeem Irfan BUKHARI, Faisal MAHMOOD
Keywords
Related Articles
- EP ID EP689989
- DOI 10.4274/tjps.galenos.2019.24445
- Views 167
- Downloads 0
Protective Effect of Dalbergia sissoo Extract Against Amyloid-β (1-42)-induced Memory Impairment, Oxidative Stress, and Neuroinflammation in Rats
Objectives: The ayurvedic literature reports that Dalbergia sissoo, a common medicinal plant for gastric and skin problems, has brain-revitalizing effects. However, the neuroprotective effect of this herb on an amyloid-β...
Statistical Design and Optimization of Sustained Release Formulations of Pravastatin
Objectives: The objective of the current study was to formulate a sustained release (SR) formulation for pravastatin. Pravastatin is a lipid lowering, biopharmaceutical classification class-III agent. Materials and Meth...
Investigation of the Presence of Sildenafil in Herbal Dietary Supplements by Validated HPLC Method
Objectives: As the first FDA-approved phosphodiesterase type 5 inhibitor, sildenafil (SDF) is widely used in the treatment of erectile dysfunction due to its strong pharmacodynamic activity. Since many food supplements a...
Tualang Honey Improves Memory and Prevents Hippocampal Changes in Prenatally Stressed Rats
Objectives: This study investigated whether the alterations in memory and hippocampus morphology and levels of malondialdehyde (MDA) and N-methyl-D-aspartate (NMDA) receptor in the hippocampus of adult rats after prenata...
Global DNA Hypomethylation and Rassf1a and c-myc Promoter Hypermethylation in Rat Kidney Cells after Bisphenol A Exposure
Objectives: Bisphenol A (BPA) is a synthetic monomer used in the production of polycarbonate and an environmental contaminant with endocrine disrupting properties. BPA release from plastic carriers is thought to cause hi...